14.07.2013 Views

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

12<br />

Facility<br />

(URL if available)<br />

Mood Disorders<br />

Centre of Excellence<br />

U<strong>BC</strong>, <strong>Clinical</strong><br />

<strong>Trials</strong> Section<br />

(www.ubcmood.ca)<br />

Multiple Sclerosis<br />

Clinic (http://research.fraserhealth.<br />

ca/clinical_trials/<br />

clinical_trials_research_groups/)<br />

Multiple Sclerosis<br />

Clinic (www.<br />

ubcneurology.com/<br />

Research_MS.html)<br />

Neurosciences<br />

Program (www.bcchildrens.ca/Services/Neurosciences/ProgramsServices.htm)<br />

Neurosurgery Division<br />

(www.surgery.<br />

ubc.ca/neurosurgery)<br />

Pacific Parkinson’s<br />

Research Centre<br />

(www.parkinsons.<br />

ubc.ca/index.html)<br />

<strong>Clinical</strong> <strong>Trials</strong><br />

Disease Focus<br />

Mood disorders<br />

(particularly depression<br />

<strong>and</strong> bipolar<br />

disorders)<br />

Therapeutic trials<br />

for MS<br />

Therapeutic trials<br />

for MS<br />

Pediatric trials in<br />

neurology, neuromuscular<br />

diseases.<br />

Cerebrovascular<br />

disease/ stroke<br />

Diagnosis <strong>and</strong><br />

management of<br />

Parkinson’s <strong>and</strong> other<br />

related disorders,<br />

such as tremor <strong>and</strong><br />

dystonia, using novel<br />

drugs, surgery, <strong>and</strong><br />

neuroimaging<br />

Types<br />

of<br />

<strong>Trials</strong>*<br />

I, II, III,<br />

IV<br />

Annual<br />

Patient<br />

Accrual<br />

Over<br />

100<br />

II, III N/A.<br />

Clinic<br />

has<br />

3,000<br />

patients<br />

II, III N/A.<br />

Over<br />

600<br />

new<br />

patients/<br />

yr<br />

Hospital/<br />

Agency<br />

(Health<br />

Authority)*<br />

U<strong>BC</strong> Hospital<br />

(VCH)<br />

Burnaby<br />

Hospital<br />

(FH)<br />

U<strong>BC</strong> Hospital<br />

(VCH)<br />

Investigators Contact<br />

• 16 investigators<br />

as listed in Appendix<br />

1<br />

• Vorobeychik,<br />

Galina<br />

• 7 investigators as<br />

listed in Appendix<br />

1<br />

Woo, Cindy. Research<br />

Coordinator. T: 604-822-<br />

7627.<br />

cinw@interchange.ubc.<br />

ca.<br />

Vorobeychik, Galina.<br />

Principal Investigator<br />

<strong>and</strong> Clinic Director. T: 604<br />

412-6405.<br />

galina.vorobeychik@<br />

fraserhealth.ca.<br />

Traboulsee, A. Head of<br />

<strong>Clinical</strong> <strong>Trials</strong> Group. T:<br />

604 822-0788. trabouls@<br />

interchange.ubc.ca.<br />

N/A N/A <strong>BC</strong>CH (PHSA) • N/A Farrell, Kevin, <strong>Clinical</strong><br />

Neurologist. T: 604-875-<br />

2976. kfarrell@cw.bc.ca.<br />

II, III Approx.<br />

200<br />

may be<br />

eligible<br />

for<br />

clinical<br />

trials<br />

I, II, III,<br />

IV<br />

VGH (VCH) • Haw, Charles<br />

• Heran, Manraj<br />

• Redekop, Gary<br />

N/A U<strong>BC</strong> Hospital<br />

(VCH)<br />

• McKeown,<br />

Martin J.<br />

• Stoessl, Jonathan<br />

• Tsui, Joseph<br />

BRITISH COLUMBIA<br />

TABLE 2. <strong>Clinical</strong> <strong>Trials</strong> Units, Centres, <strong>and</strong> Study Sites that Support <strong>Clinical</strong> <strong>Trials</strong> by<br />

Disease Area (cont’d)<br />

Redekop, Gary. Head,<br />

Division of Neurosurgery.<br />

T: 604-875-5235.<br />

gary.redekop@vch.ca.<br />

Babul, Shamin. Administrator.<br />

T: 604-822-7721.<br />

ndsb@interchange.<br />

ubc.ca

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!